Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000812·Cardlytics, Inc.
Schedule 13G ownership disclosure
CARDLYTICS INC
Common Stock · CUSIP: 14161W105
Event date: 2025-06-30
- Filing-level shares
- 2,416,909
- Percent of class
- 4.60%
- The Vanguard Group
Shares: 2,416,909 · Class: 4.60%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000812
- Form type
- SCHEDULE 13G/A
- Filer
- Cardlytics, Inc.
- CIK
- CIK 1666071
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership